What is the recommended second dose of amiodarone for a patient with refractory ventricular fibrillation who has already received 300 mg of amiodarone, multiple defibrillations, and two doses of epinephrine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Second Dose of Amiodarone: 150 mg IV/IO

The second dose of amiodarone for refractory ventricular fibrillation is 150 mg IV/IO.

Dosing Algorithm for Refractory VF

After the patient has received the initial 300 mg amiodarone dose and continues to have refractory VF despite multiple defibrillations and epinephrine, the evidence-based approach is straightforward:

Administer amiodarone 150 mg IV/IO as a single supplemental dose 1. This is the standard recommendation from the 2010 AHA ACLS Guidelines, which explicitly states: "An initial dose of 300 mg IV/IO can be followed by 1 dose of 150 mg IV/IO" 1.

Administration Details

  • Route: IV or intraosseous (IO) - both are acceptable
  • Preparation: Mix 150 mg in 100 mL D5W
  • Infusion time: Give over 10 minutes to minimize hypotension 2
  • Timing: Administer when VF/pulseless VT persists or recurs after the initial 300 mg dose

Important Caveats

This is the only recommended second dose - guidelines specify "1 dose of 150 mg," not multiple repeat doses 1. The maximum recommended dose in the first 24 hours should not exceed approximately 2100 mg total, as higher doses are associated with increased risk of hypotension 3.

Monitor for hypotension and bradycardia, which are the most common adverse effects requiring intervention 1, 2. The formulation containing polysorbate 80 (older formulation) causes more hypotension than the captisol-based formulation, though both are effective 4.

Clinical Context

While amiodarone improves short-term survival to hospital admission compared to placebo or lidocaine 1, 5, no antiarrhythmic drug has been proven to increase survival to hospital discharge or favorable neurologic outcome 1, 4, 6. The primary goal is to facilitate successful defibrillation and prevent recurrent arrhythmias, not to pharmacologically convert VF 4.

Do not delay CPR or defibrillation to establish vascular access for amiodarone - these interventions have stronger evidence for improving survival 4.

Alternative if Amiodarone Unavailable

If amiodarone is not available, lidocaine may be considered as an alternative, though it has inferior evidence 1. Initial lidocaine dose is 1 to 1.5 mg/kg IV, with additional doses of 0.5 to 0.75 mg/kg at 5-10 minute intervals up to a maximum of 3 mg/kg 1.

Related Questions

When should amiodarone be administered during cardiac arrest?
In advanced cardiac life support (ACLS), is amiodarone administered intravenously (300 mg) for ventricular fibrillation or pulseless ventricular tachycardia that persists after three defibrillations with ongoing chest compressions, can lidocaine be used as an alternative when amiodarone is unavailable, does amiodarone cause thrombophlebitis, and should it not be co‑administered with lidocaine?
Is amiodarone (antiarrhythmic medication) indicated in pulseless electrical activity (PEA) arrest?
What are the recommended drug dosages and administration guidelines for ACLS management of cardiac arrest, refractory ventricular fibrillation, symptomatic bradycardia, tachyarrhythmias, torsades de pointes, and unstable ventricular tachycardia?
Can lidocaine be given during cardiac arrest if EMS has already administered amiodarone?
What is the recommended starting dose, titration schedule, and monitoring for mirtazapine in a patient using it to treat anxiety, restlessness, and insomnia?
In a patient with chronic hepatitis B, how frequently should a whole‑abdomen ultrasound be performed for surveillance?
Should antiviral therapy be initiated after 48 hours of symptom onset?
How does midodrine affect blood pressure?
How does note taking in concierge medicine differ from that in standard primary care?
In a patient found in asystole, what is the next best action: perform endotracheal intubation, insert a supraglottic airway, obtain intravenous (IV) or intraosseous (IO) access, or conduct a pulse check?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.